Business / Finance

RSS

AMRI purchases Gadea Pharmaceutical Group for $174 million

AMRI today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product.

16 Jul 2015

Immunocore completes $320 million (£205 million) private financing round

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $320 million (GBP £205 million) private financing round.

16 Jul 2015

Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.

15 Jul 2015

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, today announced the completion of an oversubscribed $40MM Series D financing round.

15 Jul 2015

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Today, molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnerships, running GENALICE MAP in full production as their preferred tool for primary Next-Generation Sequencing (NGS) data analysis.

15 Jul 2015

Electrum Partners agrees to help develop ATTIS' business operations

The Attis Group, Inc., an Oregon-based cannabis cultivator, processor and dispensary owner, has entered into an agreement with Las Vegas, Nevada firm Electrum Partners to help develop plans to expand ATTIS' business operations.

15 Jul 2015

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.

15 Jul 2015

Efficient, sensitive and robust Chromatin immunoprecipitation methods

Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.

From Chromatrap® - Porvair Sciences Ltd 14 Jul 2015

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

Isis Pharmaceuticals, Inc. announced today that it has earned a $2.15 million milestone payment from Biogen related to advancing the ongoing pivotal Phase 3 study (CHERISH) evaluating ISIS-SMN Rx in children with spinal muscular atrophy (SMA).

14 Jul 2015

Imperial Innovations secures EIB loan to support investment in UK biotech, life science sector

Imperial Innovations Group has secured a new GBP 50 million loan from the European Investment Bank to support investment in the UK biotech and life science sector.

14 Jul 2015

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.

14 Jul 2015

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

OphthaliX Inc., a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd., announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd.

14 Jul 2015

Medgen starts shipping countertop display cases of SNORenz and SNORenz Night Time to retail stores

Medgen, Inc. today announced that it has started to ship countertop display cases of SNORenz and SNORenz Night Time to retail stores as per the terms of the company's distribution contract with retail distribution giant, Mr. Checkout.

13 Jul 2015

Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

Turtle Beach Corporation, the leading-edge audio technology company, today announced a new partnership with Audiology Management Group, Inc. for HyperSound Clear, the Company's groundbreaking hearing healthcare product planned to launch later this year.

13 Jul 2015

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.

13 Jul 2015

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Smith & Nephew plc, the global medical technology business, today announces a partnership with ScopisGmbH, the German developer and manufacturer of surgical navigation systems, as the exclusive distributor of Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium from 1 July.

13 Jul 2015

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.

13 Jul 2015

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system.

11 Jul 2015

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.

9 Jul 2015

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.

9 Jul 2015

Business / Finance

AMRI purchases Gadea Pharmaceutical Group for $174 million

Immunocore completes $320 million (£205 million) private financing round

Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Electrum Partners agrees to help develop ATTIS' business operations

Rubicon Genomics completes $2 million growth capital financing

Efficient, sensitive and robust Chromatin immunoprecipitation methods

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

Imperial Innovations secures EIB loan to support investment in UK biotech, life science sector

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

Medgen starts shipping countertop display cases of SNORenz and SNORenz Night Time to retail stores

Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Latest News